Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: Implications for multiple sclerosis

AIDS Research and Human Retroviruses

Volumn 20, Issue 4, 2004, Pages 415-423

  Brudek, Tomasz ^a   Christensen, Tove ^a   Hansen, Hans Jacob ^a   Bobecka, Jadwiga ^b   Møller Larsen, Anne ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b EGIS POLSKA Sp z oo   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ARTICLE; BLAST TRANSFORMATION; CELL ASSAY; CELL ISOLATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; HERPES VIRUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MEASLES VIRUS; MEASUREMENT; MULTIPLE SCLEROSIS; PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS; SAMPLE;

ADULT; AGED; ANTIGENS, VIRAL; CELLS, CULTURED; CYTOMEGALOVIRUS; ENDOGENOUS RETROVIRUSES; FEMALE; HERPESVIRIDAE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 3, HUMAN; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 2342620680     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922204323048168     Document Type: Article

References (28)

1. Ebers GC, Bulman DE, Sadovnick AD, Paty DW, Warren S, Hader W, Murray TJ, Seland TP, Duquette P, and Grey T: A population-based study of multiple sclerosis in twins. N Engl J Med 1986; 315:1638-1642.
2. Perron H, Garson JA, Bedin F, Beseme F, Paranhos-Baccala G, Komurian-Pradel F, Mallet F, Tuke PW, Voisset C, Blond JL, Lalande B, Seigneurin JM, and Mandrand B: Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci USA 1997;94:7583-7588.
3. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, and Perron H: Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998;351:33.
4. Christensen T, Dissing SP, Riemann H, Hansen HJ, and Møller-Larsen A: Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 1998; 352:1033.
5. Christensen T, Dissing SP, Riemann H, Hansen HJ, Munch M, Haahr S, and Möller-Larsen A: Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta Neurol Scand 2000;101:229-238.
6. Johnston JB, Silva C, Holden J, Warren KG, Clark AW, and Power C: Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann Neurol 2001;50:434-442.
7. Jolivet-Reynaud C, Perron H, Ferrante P, Becquart L, Dalbon P, and Mandrand B: Specificities of multiple sclerosis cerebrospinal fluid and serum antibodies against mimotopes. Clin Immunol 1999;93:283-293.
8. Christensen T, Sorensen PD, Hansen HJ, and Møller-Larsen A: Antibodies against a human endogenous retrovirus and the preponderance of env splice variants in multiple sclerosis patients. Mult Scler 2003;9:6-15.
9. Ferrante P, Mancuso R, Pagani E, Guerini FR, Calvo MG, Saresella M, Speciale L, and Caputo D: Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol 2000;6(Suppl 2):S109-S114.
10. Ross RT, Nicolle LE, Dawood MR, Cheang M, and Feschuk C: Varicella zoster antibodies after herpes zoster, varicella and multiple sclerosis. Can J Neurol Sci 1997;24:137-139.
11. Ross RT, Cheang M, Landry G, Klassen L, and Doerksen K: Herpes zoster and multiple sclerosis. Can J Neurol Sci 1999;26:29-32.
12. Munch M, Hvas J, Christensen T, Møller-Larsen A, and Haahr S: The implications of Epstein-Barr virus in multiple sclerosis - a review. Acta Neurol Scand Suppl 1997;169:59-64.
13. Moore FG and Wolfson C: Human herpes virus 6 and multiple sclerosis. Acta Neurol Scand 2002;106:63-83.
14. Christensen T, Jensen AW, Munch M, Haahr S, Sorensen PD, Riemann H, Hansen HJ, and Møller-Larsen A: Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol Scand Suppl 1997;169:49-58.
15. Dalgleish AG: Viruses and multiple sclerosis. Acta Neurol Scand Suppl 1997;169:8-15.
16. Munch M, Møller-Larsen A, Christensen T, Morling N, Hansen HJ, and Haahr S: B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Mult Scler 1995;1:78-81.
17. Sommerlund M, Pallesen G, Møller-Larsen A, Hansen HJ, and Haahr S: Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand 1993;87:71-76.
18. Møller-Larsen A and Christensen T: Isolation of a retrovirus from multiple sclerosis patients in self-generated Iodixanol gradients. J Virol Methods 1998;73:151-161.
19. Pyra H, Boni J, and Schupbach J: Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci USA 1994;91:1544-1548.
20. Gazzolo L and Duc DM: Direct activation of resting T lymphocytes by human T-lymphotropic virus type I. Nature 1987;326: 714-717.
21. Wucherpfennig KW, Hollsberg P, Richardson JH, Benjamin D, and Hafler DA: T-cell activation by autologous human T-cell leukaemia virus type I-infected T-cell clones. Proc Natl Acad Sci USA 1992;89:2110-2114.
22. Sotgiu S, Serra C, Mameli G, Pugliatti M, Rosati G, Arru G, and Dolei A: Multiple sclerosis-associated retrovirus and MS prognosis: An observational study. Neurology 2002;59:1071-1073.
23. Sun R, Grogan E, Shedd D, Bykovsky AF, Kushnaryov VM, Grossberg SE, and Miller G: Transmissible retrovirus in Epstein-Barr virus-producer B95-8 cells. Virology 1995;209:374-383.
24. Cianciolo GJ, Copeland TD, Oroszlan S, and Snyderman R: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 1985;230:453-455.
25. Benit L, Dessen P, and Heidmann T: Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J Virol 2001;75:11709-11719.
26. Perron H, Jouvin-Marche E, Michel M, Ounanian-Paraz A, Camelo S, Dumon A, Jolivet-Reynaud C, Marcel F, Souillet Y, Borel E, Gebuhrer L, Santoro L, Marcel S, Seigneurin JM, Marche PN, and Lafon M: Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation. Virology 2001;287:321-332.
27. Arad G, Levy R, Hillman D, and Kaempfer R: Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med 2000;6:414-421.
28. Arad G, Levy R, and Kaempfer R: Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigen. Immunol Lett 2002;82:75-78.